 Connection
David Orlicky to Pancreatic Neoplasms
This is a "connection" page, showing publications David Orlicky has written about Pancreatic Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.250 |
|
|
|
-
Dhar D, Raina K, Kumar D, Wempe MF, Bagby SM, Pitts TM, Orlicky DJ, Agarwal C, Messersmith WA, Agarwal R. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors. Mol Carcinog. 2020 10; 59(10):1227-1240.
Score: 0.110
-
Singh S, Arcaroli JJ, Orlicky DJ, Chen Y, Messersmith WA, Bagby S, Purkey A, Quackenbush KS, Thompson DC, Vasiliou V. Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma. Pancreas. 2016 Jan; 45(1):117-22.
Score: 0.079
-
Jung T, Castellana D, Klingbeil P, Cuesta Hern?ndez I, Vitacolonna M, Orlicky DJ, Roffler SR, Brodt P, Z?ller M. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia. 2009 Oct; 11(10):1093-105.
Score: 0.052
-
Claas C, Wahl J, Orlicky DJ, Karaduman H, Schn?lzer M, Kempf T, Z?ller M. The tetraspanin D6.1A and its molecular partners on rat carcinoma cells. Biochem J. 2005 Jul 01; 389(Pt 1):99-110.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|